Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant

Journal of Microbiology 2013³â 51±Ç 4È£ p.522 ~ 526
Varintip Srinon, Sunsiree Muangman, Nithima Imyaem, Veerachat Muangsombut, Sunee Korbsrisate, Natalie R. Lazar Adler, Edouard E. Galyov,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Varintip Srinon ) 
Mahidol University Faculty of Medicine Siriraj Hospital Department of Immunology

 ( Sunsiree Muangman ) 
Mahidol University Faculty of Medicine Siriraj Hospital Department of Immunology
 ( Nithima Imyaem ) 
Mahidol University Faculty of Medicine Siriraj Hospital Department of Immunology
 ( Veerachat Muangsombut ) 
Mahidol University Faculty of Medicine Siriraj Hospital Department of Immunology
 ( Sunee Korbsrisate ) 
Mahidol University Faculty of Medicine Siriraj Hospital Department of Immunology
 ( Natalie R. Lazar Adler ) 
University of Leicester Department of Infection, Immunity and Inflammation
 ( Edouard E. Galyov ) 
University of Leicester Department of Infection, Immunity and Inflammation

Abstract


Burkholderia pseudomallei, the causative agent of melioidosis, is a Gram-negative saprophytic bacterium capable of surviving within phagocytic cells. To assess the role of BopC (a type III secreted effector protein) in the pathogenesis of B. pseudomallei, a B. pseudomallei bopC mutant was used to infect J774A.1 macrophage-like cells. The bopC mutant showed significantly reduced intracellular survival in infected macrophages compared to wild-type B. pseudomallei. In addition, the bopC mutant displayed delayed escape from endocytic vesicles compared with the wild-type strain. This indicates that BopC is important, and at least in part, needed for intracellular survival of B. pseudomallei.

Å°¿öµå

Burkholderia pseudomallei; BopC; type III secretion effector; intracellular survival; phagocyte

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KAMS